๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pancreatic Cancer
Clinical trial register · China

Pancreatic Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Tianjin 7
Narrow the registerReset
Recruitment status
Phase
Site location
Tianjin7
All 1 locations
Target enrolment
to

Pancreatic Cancer trials in China

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Albumin-bound Paclitaxel (โ…ก)-Combined Regimens for Pancreatic Cancer
NCT07828756Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
147
Tianjin
2026-09-30
Not yet open
Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy
NCT07791550Pancreatic Neoplasms, Pancreatic Cancer, Drug-Related Side Effects and Adverse Reactions (MeSH Term)
Tianjin Medical University Cancer Institute and Hospital
Not applicable
96
Tianjin
2026-08-28
Not yet open
Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
NCT07796906Pancreatic Neoplasms, Pancreatic Cancer, Anxiety, Depression and/or Anxiety Symptoms
Tianjin Medical University Cancer Institute and Hospital
Not applicable
320
Tianjin
2026-08-28
Recruiting
Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery
NCT07632118Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3
288
Tianjin
2026-05-22
Recruiting
A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
NCT06944106Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
30
Tianjin
2025-03-28
Not yet open
Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
NCT06409429Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3
146
Tianjin
2024-05-01
Recruiting
Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
NCT05035147Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 4
934
Tianjin
2021-03-25
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/pancreatic-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies listing the condition Pancreatic Cancer that also match the filters currently applied.

How many Pancreatic Cancer trials are recruiting in China?

3 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pancreatic Cancer), 7 studies
PhaseStudiesRecruitingShare
Not applicable2028.6%
Phase 22128.6%
Phase 2/31014.3%
Phase 31114.3%
Phase 41114.3%

Most active sponsors

Lead sponsors with the most studies (Pancreatic Cancer)
Lead sponsorStudiesRecruiting
Tianjin Medical University Cancer Institute and Hospital73
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.